Human Papillomavirus Vaccination Among Adults and Children in 5 US States

Du, Ping; Camacho, Fabian; McCall-Hosenfeld, Jennifer S.; Lengerich, Eugene J.; Meyers, Craig; Christensen, Neil D.

doi:10.1097/phh.0000000000000271

Cited by 11 publications

(6 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar to a study of adolescents from rural-frontier states [31], we observed higher rates of completion among youth who received an influenza vaccine within the past two years. This finding could reflect the generally positive attitudes toward childhood vaccination held among Latina/o families [32,33] and/or more frequent clinic visits, which would provide greater opportunities for completion [10].…”

Section: Discussionmentioning

confidence: 97%

Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents

Gerend

Stephens

Kazmer

et al. 2019

Journal of Adolescent Health

View full text Add to dashboard Cite

The purpose of this longitudinal study was to identify individual and interpersonal factors associated with human papillomavirus (HPV) vaccine series completion in a sample of low-income Latina/o adolescent girls and boys.Methods: Caregiver-adolescent dyads (N=161) were recruited from a rural Federally Qualified Health Center in southwest Florida when the adolescent (aged 11-17) received the first dose of HPV vaccine. Dyads completed a baseline assessment that measured demographic and cultural characteristics, past medical history, provider-patient communication, HPV knowledge, health beliefs about completing the series, and the adolescent's experience receiving the first dose. Using

show abstract

Section: Discussionmentioning

confidence: 97%

Predictors of Human Papillomavirus Vaccine Completion Among Low-Income Latina/o Adolescents

Gerend

Stephens

Kazmer

et al. 2019

Journal of Adolescent Health

View full text Add to dashboard Cite

show abstract

“…Even among adolescent girls aged 13 through 15 years, the complete rate was only 29.3%. In other studies HPV vaccine completion rates widely ranged from 22% to 75% among HPV vaccine initiators because of different study populations, sampling frames and study periods [15] , [25] , [26] , [27] , [28] , [29] , [30] , [31] . The completion rate in our study was comparable with the rate (22%) observed by Dunne et al using the same data source [30] , but was much lower than the rates reported from national surveys [15] , [25] , [29] .…”

Section: Discussionmentioning

confidence: 98%

HPV vaccine completion and dose adherence among commercially insured females aged 9 through 26 years in the US

Liu

Kong

2016

Papillomavirus Research

Self Cite

View full text Add to dashboard Cite

Background Although HPV vaccination has been recommended for use in girls and young women since 2007, HPV vaccine uptake is low in the US. Methods We conducted a retrospective cohort study using the 2008–2011 MarketScan data to examine HPV vaccine completion and dose adherence among commercially insured females aged 9–26 years. We performed multivariable logistic regression models to examine factors related to HPV vaccine completion and HPV vaccine dose adherence. Results Among 378,484 females aged 9–26 years who initiated HPV vaccination, only 29.4% completed HPV vaccination. Compared with females receiving vaccines from primary care providers, those receiving vaccines from OB/GYN providers were more likely to complete the vaccine series. Age at HPV vaccine initiation, health insurance plan, seasonal pattern, and flu vaccination were also significantly associated with vaccine completion. Among 111,286 females who completed HPV vaccination, 62.4% received all doses within 30 days of the recommended schedules. Similar factors relating to HPV vaccine completion were consistently associated with HPV vaccine dose adherence. However, younger age (<22 years) and receipt of flu vaccine were negatively related to HPV vaccine dose adherence. Conclusions Intervention programs to improve HPV vaccine reminding system and reduce logistic barriers for both physicians and patients are warranted.

show abstract

“…We conducted geospatial analysis of census tracts to analyze the distribution of physicians and T he largest disparities in human papillomavirus (HPV) vaccination coverage in the United States are geographic rather than related to race, ethnicity, and socioeconomic status, varying dramatically across states and regions and by rurality. [1][2][3][4][5][6][7] For instance, HPV vaccine initiation is higher among racial and ethnic minorities and the poor, 6 while uptake is lower in rural areas compared to urban ones. A growing body of state-specific studies has identified substantial variation in vaccine coverage by counties and census tracts.…”

Section: Methodsmentioning

confidence: 99%

“…T he largest disparities in human papillomavirus (HPV) vaccination coverage in the United States are geographic rather than related to race, ethnicity, and socioeconomic status, varying dramatically across states and regions and by rurality . For instance, HPV vaccine initiation is higher among racial and ethnic minorities and the poor, while uptake is lower in rural areas compared to urban ones.…”

mentioning

confidence: 99%